Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 265

Similar articles for PubMed (Select 11720004)

1.

Progress in molecular and genetic studies of IgA nephropathy.

Novak J, Julian BA, Tomana M, Mesteck J.

J Clin Immunol. 2001 Sep;21(5):310-27. Review.

PMID:
11720004
2.

IgA nephropathy: an update.

Julian BA, Novak J.

Curr Opin Nephrol Hypertens. 2004 Mar;13(2):171-9. Review.

PMID:
15202611
3.

IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.

Novak J, Moldoveanu Z, Renfrow MB, Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J.

Contrib Nephrol. 2007;157:134-8. Review.

PMID:
17495451
4.

Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.

Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H.

Adv Otorhinolaryngol. 2011;72:60-3. doi: 10.1159/000324607. Epub 2011 Aug 18. Review.

PMID:
21865691
5.

IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.

Novak J, Julian BA, Tomana M, Mestecky J.

Semin Nephrol. 2008 Jan;28(1):78-87. doi: 10.1016/j.semnephrol.2007.10.009. Review.

6.

Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.

Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J.

J Clin Invest. 1999 Jul;104(1):73-81.

7.

Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.

Gomes MM, Suzuki H, Brooks MT, Tomana M, Moldoveanu Z, Mestecky J, Julian BA, Novak J, Herr AB.

Biochemistry. 2010 Jul 13;49(27):5671-82. doi: 10.1021/bi9019498.

8.

IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.

Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J.

Kidney Int. 2005 Feb;67(2):504-13.

PMID:
15673298
9.

Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura.

Lau KK, Wyatt RJ, Moldoveanu Z, Tomana M, Julian BA, Hogg RJ, Lee JY, Huang WQ, Mestecky J, Novak J.

Pediatr Nephrol. 2007 Dec;22(12):2067-72. Epub 2007 Oct 18.

PMID:
17943324
10.

Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.

Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, Huang WQ, Anreddy SR, Hall S, Hastings MC, Lau KK, Cook WJ, Novak J.

Kidney Int. 2007 Jun;71(11):1148-54. Epub 2007 Mar 7.

PMID:
17342176
11.

IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1.

Suzuki H, Moldoveanu Z, Hall S, Brown R, Julian BA, Wyatt RJ, Tomana M, Tomino Y, Novak J, Mestecky J.

Contrib Nephrol. 2007;157:129-33. Review.

PMID:
17495450
12.

Glycosylation of IgA1 and pathogenesis of IgA nephropathy.

Novak J, Julian BA, Mestecky J, Renfrow MB.

Semin Immunopathol. 2012 May;34(3):365-82. doi: 10.1007/s00281-012-0306-z. Epub 2012 Mar 21. Review.

PMID:
22434325
13.

IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy.

Horie A, Hiki Y, Odani H, Yasuda Y, Takahashi M, Kato M, Iwase H, Kobayashi Y, Nakashima I, Maeda K.

Am J Kidney Dis. 2003 Sep;42(3):486-96.

PMID:
12955676
14.

Structural features of IgA molecules which contribute to IgA nephropathy.

Feehally J, Allen AC.

J Nephrol. 1999 Mar-Apr;12(2):59-65. Review.

PMID:
10378660
15.

[Progress in understanding the pathogenesis of IgA nephropathy: new perspectives for the near future?].

Segarra A.

Nefrologia. 2010;30(5):501-7. doi: 10.3265/Nefrologia.pre2010.Jul.10526. Review. Spanish.

16.

IgA-containing immune complexes in the urine of IgA nephropathy patients.

Matousovic K, Novak J, Yanagihara T, Tomana M, Moldoveanu Z, Kulhavy R, Julian BA, Konecny K, Mestecky J.

Nephrol Dial Transplant. 2006 Sep;21(9):2478-84. Epub 2006 Jun 6.

17.

Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy.

Tanaka M, Seki G, Someya T, Nagata M, Fujita T.

Clin Dev Immunol. 2011;2011:470803. doi: 10.1155/2011/470803. Epub 2011 Jan 24. Review.

18.

Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.

Reily C, Ueda H, Huang ZQ, Mestecky J, Julian BA, Willey CD, Novak J.

J Immunol Res. 2014;2014:197548. doi: 10.1155/2014/197548. Epub 2014 Jul 23. Review.

19.

Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry.

Renfrow MB, Cooper HJ, Tomana M, Kulhavy R, Hiki Y, Toma K, Emmett MR, Mestecky J, Marshall AG, Novak J.

J Biol Chem. 2005 May 13;280(19):19136-45. Epub 2005 Feb 22.

20.

Interactions of human mesangial cells with IgA and IgA-containing immune complexes.

Novak J, Vu HL, Novak L, Julian BA, Mestecky J, Tomana M.

Kidney Int. 2002 Aug;62(2):465-75.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk